January 23, 2009 - Trading Update
Cyprotex PLC (LSE: CRX), the drug discovery technology and information company, announces a trading update on its performance in the calendar year ending 31 December 2008.
Trading in the months of November and December 2008 was stronger than anticipated and as a result the Directors expect 2008 full year net profits (including significant adjustments for non-recurring costs) to be in excess of the current market expectations.
Dr Anthony Baxter, CEO
Tel: +44 (0)1625 505 100
Nomura Code Securities Limited
Charles Walker, Corporate Finance
Tel: +44 (0)20 7776 1200
Tel: +44 (0)20 3178 4419